These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30550384)

  • 1. Methylphenidate-Induced Yawning Chasm in an Adolescent With Attention-Deficit/Hyperactivity Disorder That Resolved by Switching to Atomoxetine.
    Naguy A; Shoukry TM; Alamiri B
    Am J Ther; 2019; 26(6):e742-e743. PubMed ID: 30550384
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylphenidate-Induced Yawning: A Thermoregulatory Connection.
    Gallup AC; Gallup GG
    Am J Ther; 2020; 27(5):e527-e528. PubMed ID: 31082831
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined methylphenidate and atomoxetine pharmacotherapy in attention deficit hyperactivity disorder.
    Ozbaran B; Kose S; Yuzuguldu O; Atar B; Aydin C
    World J Biol Psychiatry; 2015; 16(8):619-24. PubMed ID: 26223958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry.
    Cortese S; Panei P; Arcieri R; Germinario EA; Capuano A; Margari L; Chiarotti F; Curatolo P
    CNS Drugs; 2015; 29(10):865-77. PubMed ID: 26293742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priapism With Methylphenidate Use in a Preschool-Aged Boy Resolved With Switching to Atomoxetine.
    Ekinci O; Üstündağ B; Tunali BD; Abdulrazzaq Al-Bayati MB; Demir H; Adak İ
    Clin Neuropharmacol; 2019; 42(5):184-185. PubMed ID: 31361667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of methylphenidate and atomoxetine on intrinsic brain activity in children with attention deficit hyperactivity disorder.
    Shang CY; Yan CG; Lin HY; Tseng WY; Castellanos FX; Gau SS
    Psychol Med; 2016 Nov; 46(15):3173-3185. PubMed ID: 27574878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylphenidate-Associated Onychotillomania, Myoclonus, and Enuresis Reversed by Switching to Atomoxetine.
    Naguy A; Alamiri B; El-Sori DS; Khraibut B
    Am J Ther; 2019; 26(5):e614-e616. PubMed ID: 29927775
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative Efficacy of Methylphenidate and Atomoxetine on Emotional and Behavioral Problems in Youths with Attention-Deficit/Hyperactivity Disorder.
    Shih HH; Shang CY; Gau SS
    J Child Adolesc Psychopharmacol; 2019 Feb; 29(1):9-19. PubMed ID: 30457349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential therapeutic effects of 12-week treatment of atomoxetine and methylphenidate on drug-naïve children with attention deficit/hyperactivity disorder: A counting Stroop functional MRI study.
    Chou TL; Chia S; Shang CY; Gau SS
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2300-10. PubMed ID: 26409297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and safety of methylphenidate and atomoxetine for attention-deficit hyperactivity disorder in children and adolescents: Meta-analysis based on head-to-head trials.
    Liu Q; Zhang H; Fang Q; Qin L
    J Clin Exp Neuropsychol; 2017 Nov; 39(9):854-865. PubMed ID: 28052720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atomoxetine could improve intra-individual variability in drug-naïve adults with attention-deficit/hyperactivity disorder comparably with methylphenidate: A head-to-head randomized clinical trial.
    Ni HC; Hwang Gu SL; Lin HY; Lin YJ; Yang LK; Huang HC; Gau SS
    J Psychopharmacol; 2016 May; 30(5):459-67. PubMed ID: 26905919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A network meta-analysis of atomoxetine and osmotic release oral system methylphenidate in the treatment of attention-deficit/hyperactivity disorder in adult patients.
    Bushe C; Day K; Reed V; Karlsdotter K; Berggren L; Pitcher A; Televantou F; Haynes V
    J Psychopharmacol; 2016 May; 30(5):444-58. PubMed ID: 27005307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of pharmacological treatment outcomes with atomoxetine or methylphenidate in patients with attention-deficit/hyperactivity disorder from China, Egypt, Lebanon, Russian Federation, Taiwan, and United Arab Emirates.
    Treuer T; Feng Q; Desaiah D; Altin M; Wu S; El-Shafei A; Serebryakova E; Gado M; Faries D
    Int J Clin Pract; 2014 Sep; 68(9):1152-60. PubMed ID: 24703228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Methylphenidate and Atomoxetine on Heart Rate and Systolic Blood Pressure in Young People and Adults with Attention-Deficit Hyperactivity Disorder (ADHD): Systematic Review, Meta-Analysis, and Meta-Regression.
    Liang EF; Lim SZ; Tam WW; Ho CS; Zhang MW; McIntyre RS; Ho RC
    Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30127314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany.
    Greven P; Sikirica V; Chen YJ; Curtice TG; Makin C
    Eur J Health Econ; 2017 Sep; 18(7):893-904. PubMed ID: 27817164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative short term efficacy and tolerability of methylphenidate and atomoxetine in attention deficit hyperactivity disorder.
    Garg J; Arun P; Chavan BS
    Indian Pediatr; 2014 Jul; 51(7):550-4. PubMed ID: 25031133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reconsider the diagnosis and treatment approach for ADHD].
    Jacobsson L; Hägglöf B
    Lakartidningen; 2015 Feb; 112():. PubMed ID: 25710238
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of atomoxetine and methylphenidate for problematic online gaming in adolescents with attention deficit hyperactivity disorder.
    Park JH; Lee YS; Sohn JH; Han DH
    Hum Psychopharmacol; 2016 Nov; 31(6):427-432. PubMed ID: 27859666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of attention-deficit/hyperactivity disorder in clinical practice. A retrospective study].
    López-López A; Poch-Olivé ML; López-Pisón J; Cardo-Jalón E;
    Medicina (B Aires); 2019; 79(Suppl 1):68-71. PubMed ID: 30776283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.